Feed LFCR
LF

Lifecore Biomedical, Inc.

LFCR · NASDAQ

$4.48 +1.93% (+$0.09)
1M -1.54%
Market Cap $167.3M
P/E Ratio -
Div. Yield -
ROE 376.95%
Piotroski F-Score Moderate
4/9
Valuation
95 /100
Cheap
P/S 1.36x
P/FFO N/A
P/B N/A
Growth
35 /100
Stable
Book val. growth 75.22%
Rev. growth 5.02%
FCF growth N/A
Profitability
11 /100
Weak
Net margin 30.40%
Op. margin 2.12%
FCF margin 1.47%
Quality
7 /100
Poor
ROE 376.95%
ROA 16.25%
Asset turnover 0.53x
Debt
43 /100
Moderate
Int. coverage -0.46x
Current ratio 3.87x
Net debt/EBITDA N/A
Stability
40 /100
Moderate
Rev. volatility 16.37%
EPS volatility 319.83%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about LFCR
Online

About the company

Lifecore Biomedical, Inc. (LFCR) is an American biotechnology company specializing in the development and manufacturing of medical devices and biopharmaceutical products. The company is known for its expertise in hyaluronic acid and its medical applications, offering products for ophthalmic surgery, orthopedics, and aesthetic medicine. Lifecore Biomedical focuses on innovation and continuous improvement of its products to meet the highest standards of quality and efficiency. Lifecore Biomedical, Inc. (LFCR) shares could be suitable for investors looking for investments in the biotechnology and medical devices sector with an emphasis on innovative and specialized products.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Paul Josephs

Employees

382

Headquarters

Chaska

Upcoming events

03 NOV

Earnings

Upcoming earnings report

42d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.